There are several types of muscle dystrophy (MD), each causing different types of progressive weakness and skeletal muscle degeneration. Duchenne muscular dystrophy (DMD) is the most severe form of MD and results in respiratory muscle failure, cardiomyopathy and early death. DMD results from the loss of the protein dystrophin. Using mouse models of MD, Deborah Merrick and colleagues establish a key role for dystrophin in early muscle formation. They demonstrate that dystrophin and caveolin-3 (a dystrophin-associated glycoprotein complex protein) are essential for muscle fiber formation and emergent stem cell function. This work indicates that these protein changes could be early indicators of MD, allowing earlier diagnosis and treatment to enhance the quality of life for MD patients.
Muscular dystrophy traced to prenatal origins
Muscular dystrophy traced to prenatal origins. Dis Model Mech 24 June 2009; 2 (7-8): 313. doi:
Download citation file:
Advertisement
Cited by
Interviews with Biologists @ 100 conference speakers

Explore our interviews with keynote speakers from the Biologists @ 100 conference, hosted to celebrate our publisher’s 100th anniversary, where we discuss climate change and biodiversity with Hans-Otto Pörtner and Jane Francis, health and disease with Charles Swanton and Sadaf Farooqi, and emerging technologies with Manu Prakash and Jennifer Lippincott-Schwartz.
A new perspective on disease research
DMM publishes perspectives – peer-reviewed articles that provide expert analysis of a topic important to the disease research community. Read our collection from authors presenting new or potentially controversial ideas or hypotheses, to help address future challenges and forge new directions.
Read & Publish Open Access publishing: what authors say

We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Fast & Fair peer review

Our sister journal Biology Open has recently launched the next phase of their Fast & Fair peer review initiative: offering high-quality peer review within 7 working days. To learn more about BiO’s progress and future plans, read the Editorial by Daniel Gorelick, or visit the Fast & Fair peer review page.
History of our journals

As our publisher, The Company of Biologists, turns 100 years old, read about DMM’s history and explore the journey of each of our sister journals: Development, Journal of Cell Science, Journal of Experimental Biology and Biology Open.
Other journals from
The Company of Biologists